It is a trading private limited company based in Delhi, Delhi, India, established in 2013.
2013 | Delhi, Delhi, India | ActiveKoros Pharma Private Limited, a active private limited company, was established on 04 February 2013 in Delhi, Delhi, India. Engaging in other wholesale within the trade sector, it holds CIN: U51909DL2013PTC247858. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Rajan Kumar Srivastava (Director), Ravindra Nath Upadhyay (Director), Shipra Jain (Director). Past directors included Anil Upadhyay, Ravishankar Mehta. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at 2051, Gali No. 6, Kailash Nagar, Delhi, Delhi, 110031.
U51909DL2013PTC247858
247858
04 February 2013
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Koros Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajan Kumar Srivastava | Director | 03 Mar 2018 | Current |
| Ravindra Nath Upadhyay | Director | 03 Mar 2018 | Current |
| Shipra Jain | Director | 04 Feb 2013 | Current |
| Sarvendra Kumar Mishra | Director | 05 Jun 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 20 Apr 2019 | Past |
| Pramod Abcsdd | Director | 03 Mar 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Koros Pharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Koros Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Koros Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Koros Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Koros Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Koros Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.
Koros Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Delhi. was recorded as a recent event.
The activity Rajan Kumar Srivastava was appointed as a Director was appointed as a Director on 03 Mar 2018 & has been associated with this company since 7 years 9 months . was completed.
The activity Ravindra Nath Upadhyay was appointed as a Director was appointed as a Director on 03 Mar 2018 & has been associated with this company since 7 years 9 months . was completed.
The activity Sarvendra Kumar Mishra was appointed as a Director was appointed as a Director on 05 Jun 2017 & has been associated with this company since 8 years 6 months . was completed.
Shipra Jain was appointed as a Director was appointed as a Director on 04 Feb 2013 & has been associated with this company since 12 years 10 months . was recorded as a recent event.
The CIN of Koros Pharma Private Limited is U51909DL2013PTC247858.
Koros Pharma Private Limited is headquartered at 2051, Gali No. 6, Kailash Nagar, Delhi, Delhi, 110031.
Koros Pharma Private Limited was incorporated on 04 February 2013.
The current directors of Koros Pharma Private Limited are
The primary industry of Koros Pharma Private Limited is Trade.
Koros Pharma Private Limited is unlisted.
The authorized capital of Koros Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Koros Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX